{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:23:14Z","timestamp":1761578594219},"reference-count":10,"publisher":"Japanese Society of Internal Medicine","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2169\/internalmedicine.54.4191","type":"journal-article","created":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T22:02:50Z","timestamp":1436911370000},"page":"1761-1763","source":"Crossref","is-referenced-by-count":17,"title":["Effects of Dabigatran on the Resolution of Left Ventricular Thrombus after Acute Myocardial Infarction"],"prefix":"10.2169","volume":"54","author":[{"given":"Norihiko","family":"Ohashi","sequence":"first","affiliation":[{"name":"Department of Cardiology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takenori","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mio","family":"Uchida","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michitaka","family":"Amioka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"Kaseda","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Gianstefani S, Douiri A, Delithanasis I, et al. Incidence and predictors of early left ventricular thrombus after ST-elevation myocardial infarction in the contemporary era of primary percutaneous coronary intervention. Am J Cardiol 113: 1111-1116, 2014.","DOI":"10.1016\/j.amjcard.2013.12.015"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Siebelink HM, Scholte AJ, Van de Veire NR, et al. Value of contrast echocardiography for left ventricular thrombus detection postinfarction and impact on antithrombotic therapy. Coron Artery Dis 20: 462-466, 2009.","DOI":"10.1097\/MCA.0b013e328330d58f"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Choi SH, Jeong SI, Yang JH, et al. A single-center experience with intracardiac thrombosis in children with dilated cardiomyopathy. Pediatr Cardiol 31: 264-269, 2010.","DOI":"10.1007\/s00246-009-9602-3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Schulman S, Kearon C, Kakkar AK, et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med 361: 2342-2352, 2009.","DOI":"10.1056\/NEJMoa0906598"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kaku B. Intra-cardiac thrombus resolution after anti-coagulation therapy with dabigatran in a patient with midventricular obstructive hypertrophic cardiomyopathy: a case report. J Med Case Rep 7: 238, 2013.","DOI":"10.1186\/1752-1947-7-238"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Nagamoto Y, Shiomi T, Matsuura T, et al. Resolution of a left ventricular thrombus by the thrombolytic action of dabigatran. Heart Vessels 29: 560-562, 2014.","DOI":"10.1007\/s00380-013-0403-5"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Coppens M, Eikelboom JW, Gustafsson D, Weitz JI, Hirsh J. Translational success stories: development of direct thrombin inhibitors. Circ Res 111: 920-929, 2012.","DOI":"10.1161\/CIRCRESAHA.112.264903"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ammollo CT, Semeraro F, Incampo F, Semeraro N, Colucci M. Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin-activatable fibrinolysis inhibitor. J Thromb Haemost 8: 790-798, 2010.","DOI":"10.1111\/j.1538-7836.2010.03739.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Huber K, Lip GY. Differences between ACC\/AHA and ESC Guidelines on antiplatelet therapy in patients with acute coronary syndromes. Thromb Haemost 110: 11-13, 2013.","DOI":"10.1160\/TH13-06-0453"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Dewilde WJ, Oirbans T, Verheugt FW, et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet 381: 1107-1115, 2013.","DOI":"10.1016\/S0140-6736(12)62177-1"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T15:40:51Z","timestamp":1498232451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/14\/54_54.4191\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":10,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.54.4191","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}